B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 103
Growth YoY: +3.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 151–200 of 1,117 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02329080	New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement	completed	Phase 2	79	International Extranodal Lymphoma Study Group (IELSG)OTHER	4	Jul 8, 2025	clinicaltrials
NCT02722668	UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep	completed	Phase 2	15	Masonic Cancer Center, University of MinnesotaOTHER	1	Jul 4, 2025